Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis

Myval: A Novel Transcatheter Heart Valve for the Treatment of Severe Aortic Stenosis Transcatheter aortic valve implantation (TAVI) via femoral arterial access has become the treatment of choice for elderly patients with severe calcific aortic stenosis (AS) who are at intermediate or high risk for surgical aortic valve replacement (SAVR).1,2 More recently, randomised trials have led to the approval of TAVI for patients at lower surgical risk, thereby expanding its applicabil...
Source: Radcliffe Cardiology - Category: Cardiology Authors: Source Type: research